The Current Ratio as of December 2025 (TTM) for Alphamab Oncology (9966.HK) is 4.98

According to Alphamab Oncology’s latest financial reports and current stock price. The company's current Current Ratio is 4.98. This represents a change of -10.18% compared to the average of 5.54 of the last 4 quarters.

Alphamab Oncology (9966.HK) Historical Current Ratio (quarterly & annually)

How has 9966.HK Current Ratio performed in the past?

The mean historical Current Ratio of Alphamab Oncology over the last ten years is 5.96. The current 4.98 Current Ratio has changed 8.25% with respect to the historical average. Over the past ten years (40 quarters), 9966.HK's Current Ratio was at its highest in in the June 2020 quarter at 12.73. The Current Ratio was at its lowest in in the January 2017 quarter at 0.

Alphamab Oncology (9966.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alphamab Oncology Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alphamab Oncology (9966.HK) Average Current Ratio

How has 9966.HK Current Ratio performed in the past?

The current Current Ratio of Alphamab Oncology (9966.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alphamab Oncology (9966.HK) Current Ratio vs. Peers

How is 9966.HK’s Current Ratio compared to its peers?

Alphamab Oncology’s Current Ratio is less than HBM Holdings Limited (6.05), greater than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (1.89), greater than Shanghai Haohai Biological Technology Co., Ltd. (3.77), less than Nanjing Leads Biolabs Co Ltd (0), less than Abbisko Cayman Limited (11.59), greater than Lepu Biopharma Co., Ltd. (0.63), less than CARsgen Therapeutics Holdings Limited (6.45), less than Beijing Chunlizhengda Medical Instruments Co., Ltd. (6.33), greater than CStone Pharmaceuticals (1.44), less than Ascletis Pharma Inc. (14.57),

Build a custom stock screener for Alphamab Oncology (9966.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alphamab Oncology using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alphamab Oncology (9966.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alphamab Oncology or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.